Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells

Cancer Science

Volumn 94, Issue 1, 2003, Pages 92-98

  Fei, Xiao Fang ^a   Wang, Ben Xiang ^b   Li, Tei Jin ^a   Tashiro, Shin Ichi ^c   Minami, Mutsuhiko ^d   Xing, De Jun ^e   Ikejima, Takashi ^f  

^a JILIN UNIVERSITY   (China)

^b Jilin Inst of Natural Medicine   (China)

^c SHOWA PHARMACEUTICAL UNIVERSITY   (Japan)

^d YOKOHAMA CITY UNIVERSITY   (Japan)

^e JILIN PROVINCIAL CANCER HOSPITAL   (China)

^f SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHOXY N,N DIMETHYLTRYPTAMINE; ALKALOID DERIVATIVE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 3 INHIBITOR; CATECHOLAMINE; DACTINOMYCIN; DEHYDROEVODIAMINE; DNA FRAGMENT; EVOCARPINE; EVODIA FRUIT; EVODIAMINE; EVODINE; FLUOROURACIL; INTERLEUKIN 1BETA CONVERTING ENZYME; OXEDRINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RUTAECARPINE; TESTOSTERONE; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; JAPAN; MITOCHONDRION; MOLECULAR MECHANICS; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TUMOR CELL LINE; UTERINE CERVIX CANCER;

ALKALOIDS; AMINO ACID CHLOROMETHYL KETONES; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; CASPASES; CELL DIVISION; CYSTEINE PROTEINASE INHIBITORS; DACTINOMYCIN; DNA FRAGMENTATION; DRUG SCREENING ASSAYS, ANTITUMOR; ENZYME ACTIVATION; EVODIA; FIBROSARCOMA; FLUOROURACIL; FURANS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BCL-2; HELA CELLS; HEPATOCYTES; HETEROCYCLIC COMPOUNDS WITH 4 OR MORE RINGS; HUMANS; LEUKEMIA, MONOCYTIC, ACUTE; LEUKOCYTES, MONONUCLEAR; MELANOMA; MICE; MITOCHONDRIA; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; OLIGOPEPTIDES; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; QUINAZOLINES; RATS; RATS, INBRED BUF; SARCOMA 180; TUMOR CELLS, CULTURED;

EID: 0037986592     PISSN: 13479032     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2003.tb01358.x     Document Type: Review

References (50)

1. Li SC. 1596 Pen-tsao Kang Mu. Taipei: National Research Institute of Chinese Medicine; 1976. p. 1064.
2. Anonymous. Encyclopedia of Chinese medicine. Shanghai: People's Press, People's Republic of China; 1977. p. 1118.
3. Shoji N, Umeyama A, Takemoto T, Kajiwara A, Ohizumi Y. Isolation of evodiamine, a powerful cardiotonic principle, from Evodia rutaecarpa Bentham (Rutaceae). J Pharm Sci 1986; 75: 612-3.
4. Chang HM, But PPH. Pharmacology and Applications of Chinese Medica, Vol. I. Singapore: World Scientific Publishing; 1987. p. 605.
5. Kobayashi Y, Nakano Y, Hoshikuma K, Yokoo Y, Kamiya T. The broncho-constrictive action of evodiamine, an indoloquinazoline alkaloid isolated from the fruits of Evodia rutaecarpa, on guinea-pig isolated bronchus: possible involvement of vanilloid receptors. Planta Med 2000; 66: 526-30.
6. Lin H, Tsai SC, Chen JJ, Chiao YC, Wang SW, Wang GJ, Chen CF, Wang PS. Effect of evodiamine on the secretion of testosterone in rat testicular interstitial cells. Metabolism 1999; 48: 1532-5.
7. Chiou WF, Chou CJ, Shum AY, Chen CF. The vasorelaxant effect of evodiamine in rat isolated mesenteric arteries: mode of action. Eur J Pharmacol 1992; 215: 277-83.
8. Chiou WF, Liao JF, Chen CF. Comparative study of the vasodilatory effects of three quinazoline alkaloids isolated from Evodia rutaecarpa. J Nat Prod 1996; 59: 374-8.
9. Yoshizumi M, Houchi H, Ishimura Y, Hirose M, Kitagawa T, Tsuchiya K, Minakuchi K, Tamaki T. Effect of evodiamine on catecholamine secretion from bovine adrenal medulla. J Med Invest 1997; 44: 79-82.
10. Yamahara J, Yamada T, Kitani T, Naitoh Y, Fujimura H. Antianoxic action of evodiamine, an alkaloid in Evodia rutaecarpa fruit. J Ethnopharmacol 1989; 27: 185-92.
11. Chiou WF, Sung YJ, Liao JF, Shum AJ, Chen CF. Inhibitory effect of dehydroevodiamine and evodiamine on nitric oxide production in cultured murine macrophages. J Nat Prod 1997; 60: 708-11.
12. Matsuda H, Wu JX, Tanaka T, Iinuma M, Kubo M. Antinociceptive activities of 70% methanol extract of evodiae fructus and its alkaloidal components. Biol Pharm Bull 1997; 20: 243-8.
13. Tsai TH, Lee TF, Chen CF, Wang LC. Thermoregulatory effects of alkaloids isolated from Wu-chu-yu in afebrile and febrile rats. Pharmacol Biochem Behav 1995; 50: 293-8.
14. Kano Y, Zong QN, Komatsu K. Pharmacological properties of galenical preparations. XIV. Body temperature retaining effect of the Chinese traditional medicine, "goshuyu-to" and component crude drugs. Chem Pharm Bull (Tokyo), 1991; 39: 690-2.
15. King CL, Kong YC, Wong NS, Yeung HW, Fong HH, Sankawa U. Uterotonic effect of Evodia rutaecarpa alkaloids. J Nat Prod 1980; 43: 577-82.
16. Parkin DM, Laara E, Muir CS. Estimates of the worldwide frequency of sixteen major cancers in 1980. Int J Cancer 1988; 41: 184-97.
17. Kerr JFR, Winterford CM, Harmon BV. Apoptosis: its significance in cancer and cancer therapy. Cancer 1994; 73: 2013-26.
18. Oyaizu N, Pahwa S. Role of apoptosis in HIV disease pathogenesis. J Clin Immunol 1995; 15: 217-31.
19. Han DKM, Haudenschild CC, Hong MK, Tinkle BT, Leon MB, Liau G. Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. Am J Pathol 1995; 147: 267-77.
20. Hickmann JA. Apoptosis induced by anticancer drugs. Cancer Metastasis Rev 1992; 11: 121-39.
21. Chen Z, Naito M, Mashima T, Tsuruo T. Activation of actin-cleavable interleukin 1β-converting enzyme (ICE) family protease CPP32 during chemotherapeutic agent-induced apoptosis in ovarian carcinoma cells. Cancer Res 1996; 56: 5224-9.
22. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW. CPP32/apopain is a key interleukin-1β-converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 1996; 271: 1841-4.
23. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
24. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
25. Hockenbery D, Nunez G, Milliman C, Schreitber RD, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
26. Thornberry NA, Lazebnik Y. Caspase: enemies within. Science 1998; 281: 1312-6.
27. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995; 376: 37-43.
28. Ohta T, Kinoshita T, Naito M, Nozaki T, Masutani M, Tsuruo T, Miyajima A. Requirement of the caspase-3/CPP32 protease cascade for apoptotic death following cytokine deprivation in hematopoietic cells. J Biol Chem 1997; 272: 23111-6.
29. Enari M, Talanian RV, Wong WW, Nagata S. Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 1996; 380: 723-6.
30. Los M, Van DCM, Penning LC, Schenk H, Westendorp M, Baeuerle PA, Droqe W, Krammer PH, Fiers W, Schulze OK. Requirement of an ICE/CED-3 protease for Fas/APO-1 mediated apoptosis. Nature 1995; 375: 81-3.
31. Zou H, Henzel WJ, Liu X, Lutschg A, Wang X. Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 1997; 90: 405-13.
32. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997; 91: 479-89.
33. Kroemer G, Petit P, Zamzami N, Vayssiere JL, Mignotte B. The biochemistry of programmed cell death. FASEB J 1995; 9: 1277-87.
34. Hengartner MO, Horvitz HR. C. elegans cell survival gene ced-9 encodes a functional homolog of the mammalian proto-oncogene bcl-2. Cell 1994; 76: 665-76.
35. Hockenbery D, Nunez G, Milliman C, Schreitber RD, Korsmeyer S. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 1990; 348: 334-6.
36. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science 1997; 275: 967-9.
37. Xu DM. Chemistry of Ginseng. In: Wang BX, editor. Ginseng Research, Tianjin: Scientific and Technical Press; 1984. p. 51-68.
38. Itoh S, Hattori T, Hayashi H, Mizutani Y, Todo M, Takii T, Yang D, Lee JC, Matsufuji S, Murakami Y, Chiba T, Onozaki K. Antiproliferative effect of IL-1 is mediated by p38 mitogen-activated protein kinase in human melanoma cell A375. J Immunol 1999; 162: 7434-40.
39. Yano H, Mizoguchi M, Fukuda K, Haramaki M, Ogasawara S, Momosaki S, Kojiro M. The herbal medicine sho-saiko-to inhibits proliferation of cancer cell lines by inducing apoptosis and arrest at the G0/G1 phase. Cancer Res 1994; 54: 448-54.
40. Lamarre D, Talbot B, De MG, Laplante C, Leduc Y, Mazen A, Poirier GG. Structural and functional analysis of poly (ADP-ribose) polymerase: an immunological study. Biochim Biophys Acta 1998; 950: 147-60.
41. Rao L, White E. Bcl-2 and ICE family of apoptotic regulators: marking a connection. Curr Opin Genet Dev 1997; 7: 52-8.
42. Takahashi A, Earnshaw WC. ICE-related proteases in apoptosis. Curr Opin Genet Dev 1996; 6: 50-5.
43. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Sheuchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME, Dixit VM. FLICE, a novel FADD-homologous ICE/CED3 like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996; 85: 817-27.
44. Villa P, Kaufmann SH, Earnshaw WC. Caspases and caspase inhibitors. Trends Biochem Sci 1997; 22: 388-93.
45. Golstein P. Controlling cell death. Science 1997; 275: 1081-2.
46. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG, Shore GC. Bcl-2 and adenovirus EIB l9kDA protein prevent EIA-induced processing of CPP32 and cleavage of poly (ADP-ribose) polymerase. Oncogene 1996; 12: 529-35.
47. Erhardt P, Cooper GM. Activation of the CPP32 apoptotic protease by distinct signaling pathways with differential sensitivity to Bcl-xL. J Biol Chem 1996; 271: 17601-4.
48. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jone DP, Wang X. Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 1997; 275: 1129-32.
49. Perlman H, Zhang XJ, Chen MW, Walsh K, Buttyan R. An elevated bax/bcl-2 ratio corresponds with the onset of prostate epithelial cell apoptosis. Cell Death Differ 1999; 6: 48-54.
50. Fanidi A, Harrington EA, Evan GI. Cooperative interaction between c-myc and bcl-2 proto-oncogenes. Nature 1992; 359: 554-6.